|
시장보고서
상품코드
1930054
생명과학 분석 시장 : 시장 규모, 점유율 및 성장률, 산업 분석 - 유형별, 용도별, 지역별 인사이트 및 예측(2025-2034년)Life Science Analytics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034 |
||||||
생명과학 분석 시장의 성장 동인
세계 생명과학 분석 시장은 2025년 137억 8,000만 달러로 평가되었습니다. 2026년에는 150억 달러로 성장하고 2034년에는 357억 달러에 달할 것으로 예측됩니다. 예측 기간 동안 11.45%의 견고한 CAGR을 보이고 있습니다. 2025년에는 북미가 43.3%의 점유율로 시장을 주도할 것으로 예상되며, 이는 높은 R&D 투자, 탄탄한 의료 IT 인프라, 임상시험의 고급 분석 기술 보급에 힘입은 것으로 분석됩니다.
생명과학 분석은 제약회사, 바이오테크놀러지 기업, 위탁연구기관(CRO)이 신약개발, 임상시험, 맞춤치료, 업무 효율을 최적화하기 위한 소프트웨어, 솔루션, 분석 용도를 포괄합니다. 시장의 주요 기업으로는 Oracle, SAS 인스티튜트, 액센츄어, 비바 시스템즈, IBM 등을 들 수 있습니다. AI, 머신러닝, 클라우드 기반 분석 플랫폼의 도입 확대가 시장 성장을 가속하고 있습니다.
예를 들어, 2024년 10월 Oracle은 생명과학을 위한 AI 탑재 솔루션 'Oracle 애널리틱스 인텔리전스(Oracle Analytics Intelligence)를 발표하며, 다양한 데이터 소스에서 빠른 지식 추출을 가능하게 함으로써 보다 정밀한 치료제 개발을 가속화할 수 있도록 했습니다.
시장 역학
시장 성장 촉진요인
임상시험에서 분석 도구의 활용이 확대되면서 환자 모집, 실시간 모니터링, 개인 맞춤형 치료법 개발이 개선되고 있습니다. SAS Life Science Analytics Framework, ClinACT 등의 분석 플랫폼을 활용한 전임상시험(유효성, 독성, 안전성 평가)의 가속화로 의약품 개발 비용과 기간을 단축하고 있습니다. 클래리베이트와 VeriSIM Life의 제휴(2023년 12월), IQVIA의 'One Home for Sites' 도입(2024년 6월)과 같은 전략적 파트너십을 통해 데이터 분석 및 임상 업무의 효율화를 더욱 촉진하고 있습니다.
또한, 병원의 의료 데이터 관리 플랫폼 도입 확대와 의료비 지출 증가가 시장 성장을 견인하고 있습니다. 예를 들어, 미국의 국민 의료비 지출은 2028년까지 6조 3,000억 달러에 달할 것으로 예상되며, 규제 준수, 비용 효율성 평가, 업무 효율화를 위한 분석 플랫폼에 대한 수요를 견인하고 있습니다.
시장 성장 억제요인
높은 도입 비용(10만 달러에서 125만 달러 범위)과 데이터 유출에 대한 우려로 인해 도입이 저해되고 있습니다. 클라우드 기반 분석은 효율적이지만, 사이버 보안 위험도 수반합니다. 예를 들어, 대규모 데이터 유출의 평균 비용은 2022년 2억 4,100만 달러로 증가하여 데이터 보안의 중요성이 더욱 부각되고 있습니다.
기회
신흥 시장에서는 의료 인프라의 정비와 디지털화가 진행되면서 수익성 높은 기회가 창출되고 있습니다. 기업들은 인도, 중국, 아프리카 등 미개척 지역에 진출하기 위해 분석 솔루션에 대한 투자를 진행하고 있습니다. 예를 들어, PBR Life Sciences(2024년 12월)는 아프리카에서 의료 분석 도구를 확장하기 위해 100만 달러의 자금 조달을 확보했습니다.
과제
데이터 통합의 복잡성, 숙련된 전문가 부족, 엄격한 규제 준수 요건 등은 생명과학 분석 툴을 세계 비즈니스에 적용하는 데 있어 여전히 과제로 남아있습니다.
시장 세분화
유형별로는 2026년 서비스가 61.7%의 점유율로 선두를 차지할 것으로 예측됩니다. 이는 임상시험, 의약품 개발, 규제 준수 분야에서 광범위하게 채택된 배경에 기인합니다. 소프트웨어 솔루션은 Axtria의 AI 기반 솔루션(2024년 3월) 등 혁신 기술에 힘입어 꾸준한 성장이 예상됩니다.
제공 방식별로는 온디맨드/클라우드 서비스가 2026년 53.08%의 점유율로 1위를 차지했습니다. 제약사 및 CRO(의약품 개발 수탁기관)에서의 채용이 추진력이 되어 업무의 효율화와 임상시험 분석의 신속성을 실현하고 있습니다.
용도별: 임상 연구 분석은 2026년 53.44%의 점유율을 차지할 것으로 예상되며, 의약품 개발, 임상시험 및 연구 분야에서의 채택이 주도하고 있습니다. 정밀의료와 업무 효율화에 대한 수요 증가로 상업적 분석, 개인 맞춤형 치료, 공급망 분석 분야도 성장하고 있습니다.
최종 사용자별: 제약 및 생명공학 기업이 2026년 40.09%의 점유율을 차지할 것으로 예상되며, 연구개발에 대한 지속적인 투자로 선도적인 위치를 유지할 것으로 보입니다. CRO 및 의료기기 기업들은 특히 개인 맞춤형 의료 및 분석 솔루션의 도입 확대에 따라 괄목할 만한 성장세를 보이고 있습니다.
지역별 분석
북미는 2025년 59억 7,000만 달러로 1위를 차지할 것으로 예상되며, 2026년 59억 5,000만 달러에 달할 것으로 예측됩니다. 유럽은 의료 분석 분야에 대한 강력한 자금 투입으로 그 뒤를 잇고 있습니다. 영국 시장은 2026년 8억 6,000만 달러, 독일은 10억 1,000만 달러로 예측됩니다. 아시아태평양은 인도, 중국, 일본의 신흥 의료 인프라, 임상시험 및 투자에 힘입어 가장 높은 성장률을 보일 것으로 예측됩니다. 라틴아메리카는 꾸준한 성장세를 보이고 있으며, 중동 및 아프리카은 도입이 제한적이지만 투자 기회가 확대되고 있어 성장 속도는 완만할 것으로 예측됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 생명과학 분석 시장 분석 : 인사이트·예측(2021-2034년)
제6장 북미 생명과학 분석 시장 분석 : 인사이트와 예측(2021-2034년)
제7장 유럽 생명과학 분석 시장 분석 : 인사이트와 예측(2021-2034년)
제8장 아시아태평양 생명과학 분석 시장 분석 : 인사이트와 예측(2021-2034년)
제9장 라틴아메리카 생명과학 분석 시장 분석 : 인사이트와 예측(2021-2034년)
제10장 중동 및 아프리카 생명과학 분석 시장 분석 : 인사이트와 예측(2021-2034년)
제11장 경쟁 분석
LSHGrowth Factors of life science analytics Market
The global life science analytics market was valued at USD 13.78 billion in 2025 and is projected to grow to USD 15 billion in 2026, ultimately reaching USD 35.7 billion by 2034, exhibiting a robust CAGR of 11.45% during the forecast period. North America led the market in 2025 with a 43.3% share, driven by high R&D investment, strong healthcare IT infrastructure, and widespread adoption of advanced analytics in clinical trials.
Life science analytics encompasses software, solutions, and analytical applications that enable pharmaceutical, biotechnology, and contract research organizations (CROs) to optimize drug discovery, clinical trials, personalized therapies, and operational efficiency. Major players in the market include Oracle Corporation, SAS Institute Inc., Accenture, Veeva Systems Inc., and IBM, among others. The growing adoption of AI, machine learning, and cloud-based analytics platforms is fueling market expansion.
For example, in October 2024, Oracle launched AI-powered Oracle Analytics Intelligence for life sciences, enabling faster insights from diverse data sources, thus accelerating the development of therapies with greater precision.
Market Dynamics
Growth Factors:
The increasing use of analytical tools in clinical trials is improving patient recruitment, real-time monitoring, and development of personalized therapies. Preclinical studies for efficacy, toxicity, and safety assessment are being accelerated using analytical platforms like SAS Life Science Analytics Framework and ClinACT, reducing both cost and time for drug development. Strategic partnerships such as Clarivate and VeriSIM Life (December 2023) and IQVIA's 'One Home for Sites' (June 2024) are further enhancing the efficiency of data analysis and clinical operations.
Additionally, the growing adoption of healthcare data management platforms in hospitals, coupled with rising healthcare expenditures, supports market growth. For instance, the U.S. National Healthcare Expenditure is projected to reach USD 6.3 trillion by 2028, driving demand for analytics platforms for regulatory compliance, cost-effectiveness assessment, and operational efficiency.
Restraints:
High implementation costs, which may range from USD 100,000 to USD 1.25 million, and concerns over data breaches are restraining adoption. Cloud-based analytics, while efficient, also pose cybersecurity risks. For example, the average cost of a mega data breach increased to USD 241 million in 2022, highlighting the importance of data security.
Opportunities:
Emerging markets present lucrative opportunities due to rising healthcare infrastructure and digitalization. Companies are investing in analytics solutions to penetrate untapped regions such as India, China, and Africa. For instance, PBR Life Sciences (December 2024) secured USD 1 million funding to expand healthcare analytics tools in Africa.
Challenges:
Data integration complexities, shortage of skilled professionals, and stringent regulatory compliance requirements remain challenges in deploying life science analytics tools across global operations.
Market Segmentation
By Type: Services dominated with a 61.7% share in 2026, driven by widespread adoption in clinical trials, drug development, and regulatory compliance. Software & solutions are expected to grow steadily, supported by innovations such as Axtria's AI-driven solutions (March 2024).
By Delivery: On-demand/cloud services led with 53.08% share in 2026, fueled by adoption in pharmaceutical companies and CROs, enabling streamlined operations and faster clinical trial analysis.
By Application: Clinical research analytics held a 53.44% share in 2026, driven by adoption in drug development, clinical trials, and research. Commercial analytics, personalized therapy, and supply chain analytics segments are also experiencing growth due to rising demand for precision medicine and operational efficiency.
By End-Users: Pharma & biotech companies dominated with a 40.09% share in 2026, owing to continuous investment in R&D. CROs and medical device companies are witnessing substantial growth, particularly with increasing adoption of personalized medicine and analytics solutions.
Regional Insights
North America led with USD 5.97 billion in 2025, projected to reach USD 5.95 billion in 2026, driven by established R&D centers and adoption of analytical tools. Europe follows with strong funding for healthcare analytics; the UK market is projected at USD 0.86 billion in 2026, Germany at USD 1.01 billion. Asia Pacific is expected to register the highest growth, supported by emerging healthcare infrastructure, clinical trials, and investments in India, China, and Japan. Latin America shows steady growth, while the Middle East & Africa grow slower due to limited adoption but emerging investment opportunities.
Competitive Landscape
Key players include Oracle, Accenture, SAS Institute, IQVIA, Veeva Systems, and IBM, focusing on collaborations, acquisitions, and technological innovations to expand market share. Notable developments include Accenture's acquisition of consus.health (August 2024) and Oracle's CancerMPact service (September 2024) for global cancer treatment trend analysis.
Conclusion
The global life science analytics market is on a strong growth trajectory, expanding from USD 13.78 billion in 2025 to USD 15 billion in 2026 and expected to reach USD 35.7 billion by 2034 at a CAGR of 11.45%. The market is driven by the growing adoption of AI, cloud services, and advanced analytics in pharma, biotech, and CROs for drug development, clinical research, and personalized medicine. North America continues to lead, while Asia Pacific offers the fastest growth potential. Despite challenges such as high implementation costs, data integration issues, and regulatory compliance, technological innovations, strategic partnerships, and the rising demand for cloud-based services and personalized therapies are poised to sustain market expansion and transform the life sciences industry globally.
Segmentation By Type
- Software & Solutions
- Services
By Delivery
- On-premise
- On-demand
By Application
- Commercial Analytics
- Personalized Therapy
- Clinical Research Analytics
- Supply Chain Analytics
By End User
- Medical Device Companies
- Pharma & Biotech Companies
- Contract Research Organizations
- Others
By Region
- North America (By Type, By Delivery, By Application, By End Users, By Country)
- U.S.
- Canada
- Europe (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
- Japan
- China
- India
- Australia
- South Korea
- Rest of the Asia Pacific
- Latin America (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Technological Advancements in Life Science Analytics
- 4.2. Key Industry Developments- Mergers, Acquisitions & Partnerships
- 4.3. New Product Launches
- 4.4. Impact of COVID-19 on the Market
5. Global Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Software & Solutions
- 5.1.2. Services
- 5.2. Market Analysis, Insights and Forecast - By Delivery
- 5.2.1. On-premise
- 5.2.2. On-demand
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Commercial Analytics
- 5.3.2. Personalized Therapy
- 5.3.3. Clinical Research Analytics
- 5.3.4. Supply Chain Analytics
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Medical Device Companies
- 5.4.2. Pharma & Biotech Companies
- 5.4.3. Contract Research Organizations
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East and Africa
6. North America Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Software & Solutions
- 6.1.2. Services
- 6.2. Market Analysis, Insights and Forecast - By Delivery
- 6.2.1. On-premise
- 6.2.2. On-demand
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Commercial Analytics
- 6.3.2. Personalized Therapy
- 6.3.3. Clinical Research Analytics
- 6.3.4. Supply Chain Analytics
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Medical Device Companies
- 6.4.2. Pharma & Biotech Companies
- 6.4.3. Contract Research Organizations
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Software & Solutions
- 7.1.2. Services
- 7.2. Market Analysis, Insights and Forecast - By Delivery
- 7.2.1. On-premise
- 7.2.2. On-demand
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Commercial Analytics
- 7.3.2. Personalized Therapy
- 7.3.3. Clinical Research Analytics
- 7.3.4. Supply Chain Analytics
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Medical Device Companies
- 7.4.2. Pharma & Biotech Companies
- 7.4.3. Contract Research Organizations
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Software & Solutions
- 8.1.2. Services
- 8.2. Market Analysis, Insights and Forecast - By Delivery
- 8.2.1. On-premise
- 8.2.2. On-demand
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Commercial Analytics
- 8.3.2. Personalized Therapy
- 8.3.3. Clinical Research Analytics
- 8.3.4. Supply Chain Analytics
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Medical Device Companies
- 8.4.2. Pharma & Biotech Companies
- 8.4.3. Contract Research Organizations
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. South Korea
- 8.5.6. Rest of Asia Pacific
9. Latin America Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Software & Solutions
- 9.1.2. Services
- 9.2. Market Analysis, Insights and Forecast - By Delivery
- 9.2.1. On-premise
- 9.2.2. On-demand
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Commercial Analytics
- 9.3.2. Personalized Therapy
- 9.3.3. Clinical Research Analytics
- 9.3.4. Supply Chain Analytics
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Medical Device Companies
- 9.4.2. Pharma & Biotech Companies
- 9.4.3. Contract Research Organizations
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Software & Solutions
- 10.1.2. Services
- 10.2. Market Analysis, Insights and Forecast - By Delivery
- 10.2.1. On-premise
- 10.2.2. On-demand
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Commercial Analytics
- 10.3.2. Personalized Therapy
- 10.3.3. Clinical Research Analytics
- 10.3.4. Supply Chain Analytics
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Medical Device Companies
- 10.4.2. Pharma & Biotech Companies
- 10.4.3. Contract Research Organizations
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. SAS Institute Inc.
- 11.2.1.1. Overview
- 11.2.1.2. SWOT Analysis
- 11.2.1.3. Recent Developments
- 11.2.1.4. Strategies
- 11.2.1.5. financials (Based on Availability)
- 11.2.2. Accenture
- 11.2.2.1. Overview
- 11.2.2.2. SWOT Analysis
- 11.2.2.3. Recent Developments
- 11.2.2.4. Strategies
- 11.2.2.5. financials (Based on Availability)
- 11.2.3. Veeva Systems
- 11.2.3.1. Overview
- 11.2.3.2. SWOT Analysis
- 11.2.3.3. Recent Developments
- 11.2.3.4. Strategies
- 11.2.3.5. financials (Based on Availability)
- 11.2.4. IBM
- 11.2.4.1. Overview
- 11.2.4.2. SWOT Analysis
- 11.2.4.3. Recent Developments
- 11.2.4.4. Strategies
- 11.2.4.5. financials (Based on Availability)
- 11.2.5. Oracle
- 11.2.5.1. Overview
- 11.2.5.2. SWOT Analysis
- 11.2.5.3. Recent Developments
- 11.2.5.4. Strategies
- 11.2.5.5. financials (Based on Availability)
- 11.2.6. Analytics8
- 11.2.6.1. Overview
- 11.2.6.2. SWOT Analysis
- 11.2.6.3. Recent Developments
- 11.2.6.4. Strategies
- 11.2.6.5. financials (Based on Availability)
- 11.2.7. IQVIA Inc
- 11.2.7.1. Overview
- 11.2.7.2. SWOT Analysis
- 11.2.7.3. Recent Developments
- 11.2.7.4. Strategies
- 11.2.7.5. financials (Based on Availability)
- 11.2.8. Other Prominent Players
- 11.2.8.1. Overview
- 11.2.8.2. SWOT Analysis
- 11.2.8.3. Recent Developments
- 11.2.8.4. Strategies
- 11.2.8.5. financials (Based on Availability)
- 11.2.1. SAS Institute Inc.
